{"id":"NCT02382939","sponsor":"Novo Nordisk A/S","briefTitle":"A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency","officialTitle":"A Multicentre, Multinational, Randomised, Open-labelled, Parallel-group, Active-controlled Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-02-12","primaryCompletion":"2016-01-04","completion":"2016-01-04","firstPosted":"2015-03-09","resultsPosted":"2020-06-16","lastUpdate":"2020-07-09"},"enrollment":92,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Adult Growth Hormone Deficiency","Growth Hormone Disorder"],"interventions":[{"type":"DRUG","name":"somapacitan","otherNames":[]},{"type":"DRUG","name":"somatropin","otherNames":[]}],"arms":[{"label":"somapacitan","type":"EXPERIMENTAL"},{"label":"hGH (somatropin)","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Europe and Asia. The aim of the trial is to compare the safety of once weekly dosing of somapacitan (administered with an investigational pen) with daily Norditropin® FlexPro® (somatropin delivered within a prefilled pen) for 26 weeks in previously human growth hormone (hGH) treated adults with growth hormone deficiency.","primaryOutcome":{"measure":"Incidence of Adverse Events","timeFrame":"Weeks 0 - 26","effectByArm":[{"arm":"Norditropin","deltaMin":530.8,"sd":null},{"arm":"Somapacitan","deltaMin":514.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":28,"countries":["Denmark","France","Germany","Japan","Sweden","United Kingdom"]},"refs":{"pmids":["36380045"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":31},"commonTop":["Nasopharyngitis","Headache","Fatigue","Arthralgia","Asthenia"]}}